MatthewMLaughonMD

PubMed

• Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole.
  Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, Michael Cohen-Wolkowiez, Elizabeth J Thompson, Saranya Venkatachalam, Michael J Smith, Catherine Bendel, Josep...> ;Antimicrobial Agents and Chemotherapy. 2024 Apr 3
• Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities.
  An N Massaro, Beth Boyer, Mira Gill, Dure Kim, Matthew Laughon, Michele Walsh, Monica E Lemmon, Betsy Pilon, Gerri Baer> ;The Journal of Pediatrics. 2024 Feb 22
• 1 citations
  Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial.
  Tarah T Colaizy, Brenda B Poindexter, Scott A McDonald, Edward F Bell, Waldemar A Carlo, Susan J Carlson, Sara B DeMauro, Kathleen A Kennedy, Leif D Nelin, Pablo J Sán...> ;JAMA. 2024 Feb 20
• Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit.
  Ibrahim, A., Laughon, C., Moore, K., Tejada, A., Tran, D., Kilpatrick, R., Greenberg, R., Clark, R., Lang, J., Tang, M., Hornik, C., Zimmerman, K., Laughon, M.> ;Journal of Perinatology. 2024 Jan 31
• Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network.
  Rysavy, M., Carper, B., Chock, V., Backes, C., Bell, E., McNamara, P., Kaluarachchi, D., Laughon, M., Colaizy, T.> ;The Journal of Pediatrics. 2024 Mar 1
• Diuretic Tolerance to Repeated-Dose Furosemide in Infants Born Very Preterm with Bronchopulmonary Dysplasia.
  Nicolas A Bamat, Matthew Huber, Justine Shults, Yun Li, Zili Zong, Athena Zuppa, Eric C Eichenwald, Matthew M Laughon, Sara B DeMauro, Kristin J McKenna, Benjamin Lask...> ;The Journal of Pediatrics. 2024 Mar 1
• Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants.
  Matthew F Pizzuto, Matthew M Laughon, Wesley M Jackson> ;Expert Opinion on Pharmacotherapy. 2023 Sep 14
• A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy.
  Wesley Jackson, Daniel Gonzalez, Rachel G Greenberg, Yueh Z Lee, Matthew M Laughon> ;Journal of Perinatology. 2024 Apr 1
• 1 citations
  Early antibiotic exposure in very-low birth weight infants and infection risk at 3-7 days after birth.
  Sarah A Coggins, Zachary Willis, Daniel K Benjamin, Sagori Mukhopadhyay, Matthew Laughon, Rachel G Greenberg, Reese H Clark, Karen M Puopolo> ;Journal of Perinatology. 2023 Sep 1
• Patent Ductus Arteriosus in Premature Infants: Clinical Trials and Equipoise.
  Macrina B Liguori, Sanoj K M Ali, Neidín Bussman, Tarah Colaizy, Tim Hundscheid, Nilkant Phad, Ronald Clyman, Willem-Pieter de Boode, Koert de Waal, Afif El-Khuffash, ...> ;The Journal of Pediatrics. 2023 Oct 1
• 1 citations
  Supporting Career Transitions of Senior Faculty: Perspectives of Chairs and Full Professors.
  Sue Tolleson-Rinehart, Susan L Rosenthal, Ariel M de Roche, Matthew Laughon, Taylor B Sewell, Christina M Rivera, David Gozal, Raphael Hirsch, Jordan S Orange, Stephan...> ;The Journal of Pediatrics. 2024 Jan 1
• Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child ...
  Samuel J Gentle, Matthew A Rysavy, Lei Li, Matthew M Laughon, Ravi M Patel, Erik A Jensen, Susan Hintz, Namasivayam Ambalavanan, Waldemar A Carlo, Kristi Watterberg, ,...> ;JAMA Network Open. 2023 May 1
• 7 citations
  Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
  Erik A Jensen, Laura Elizabeth Wiener, Matthew A Rysavy, Kevin C Dysart, Marie G Gantz, Eric C Eichenwald, Rachel G Greenberg, Heidi M Harmon, Matthew M Laughon, Krist...> ;JAMA Network Open. 2023 May 1
• 2 citations
  Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.
  Jason E Lang, Chi D Hornik, Karen Martz, Juliana Jacangelo, Ravinder Anand, Rachel Greenberg, Christoph Hornik, Kanecia Zimmerman, P Brian Smith, Daniel K Benjamin, Ma...> ;Contemporary Clinical Trials Communications. 2022 Dec 1
• Indomethacin Prophylaxis in Preterm Infants: Changes over Time.
  Samantha F Curtis, C Michael Cotten, Matthew Laughon, Noelle Younge, Jennifer Peterson, Reese H Clark, Rachel G Greenberg> ;American Journal of Perinatology. 2022 Sep 29
• 1 citations
  Indomethacin Prophylaxis in Preterm Infants: Changes over Time.
  Samantha F Curtis, C Michael Cotten, Matthew Laughon, Noelle Younge, Jennifer Peterson, Reese H Clark, Rachel G Greenberg> ;American Journal of Perinatology. 2022 Oct 19
• 1 citations
  Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease.
  Jessica E Ericson, Daniel K Benjamin Jr, Felix Boakye-Agyeman, Stephen J Balevic, C Michael Cotten, Felice Adler-Shohet, Matthew Laughon, Brenda Poindexter, Barrie Har...> ;Early Human Development. 2022 Jul 1
• 21 citations
  Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants.
  Rachel G Greenberg, Scott A McDonald, Matthew M Laughon, David Tanaka, Erik Jensen, Krisa Van Meurs, Eric Eichenwald, Jane E Brumbaugh, Andrea Duncan, Michele Walsh, A...> ;Archives of Disease in Childhood. Fetal and Neonatal Edition. 2022 Jun 21
• 3 citations
  Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.
  Erik A Jensen, Matthew M Laughon, Sara B DeMauro, C Michael Cotten, Barbara Do, Waldemar A Carlo, Kristi L Watterberg> ;Seminars in Perinatology. 2022 Nov 1
• 2 citations
  Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death.
  Samuel J Gentle, Benjamin Carper, Matthew M Laughon, Erik A Jensen, Austin Williams, Colm P Travers, Namasivayam Ambalavanan, Charitharth V Lal, Waldemar A Carlo> ;Journal of Perinatology. 2022 Apr 1
• 2 citations
  Association between postmenstrual age and furosemide dosing practices in very preterm infants.
  Nicolas A Bamat, Elizabeth J Thompson, Rachel G Greenberg, Scott A Lorch, Athena F Zuppa, Eric C Eichenwald, Veeral N Tolia, Reese H Clark, P Brian Smith, Christoph P ...> ;Journal of Perinatology. 2022 Apr 1
• Correction: Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death.
  Samuel J Gentle, Benjamin Carper, Matthew M Laughon, Erik A Jensen, Austin Williams, Colm P Travers, Namasivayam Ambalavanan, Charitharth V Lal, Waldemar A Carlo> ;Journal of Perinatology. 2022 Apr 1
• 30 citations
  Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
  Brion, L. P., Kristi L Watterberg, Michele C Walsh, Lei Li, Sanjay Chawla, Carl T D'Angio, Ronald N Goldberg, Susan R Hintz, Matthew M Laughon, Bradley A Yoder, Kathle...> ;The New England Journal of Medicine. 2022 Mar 24
• 3 citations
  Differential placental CpG methylation is associated with chronic lung disease of prematurity
  Wesley M. Jackson, Hudson P. Santos, Hadley J. Hartwell, William A. Gower, Divya Chhabra, James S. Hagood, Matthew M. Laughon, Alexis Payton, Lisa Smeester, Kyle Roell...> ;Pediatric Research. 2021 Dec 2
• 4 citations
  Mortality Risk Factors Among Infants Receiving Dialysis in the Neonatal Intensive Care Unit
  Keia R. Sanderson, Bradley A. Warady, William A. Carey, Veeral N. Tolia, Marcella H. Boynton, Daniel K. Benjamin, Wesley M. Jackson, Matthew M. Laughon, Reese H. Clark...> ;The Journal of Pediatrics. 2021 Nov 16
• Join now to see all

Journal Articles

• Agreement of an Echocardiogram-Based Diagnosis of Pulmonary Hypertension in Infants at Risk for Bronchopulmonary Dysplasia Among Masked Reviewers  
  Rachel D Torok, Matthew M Laughon, Andrew W McCrary, Christoph P Hornik, Jennifer S Li, Nature
• Characterization of the Population Pharmacokinetics of Ampicillin in Neonates Using an Opportunistic Study Design  
  Tremoulet A, Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Salgado A, Ian-U Chong S, Melloni C, Gao J, Benjamin DK Jr, Capparelli EV, Cohen-Wolkowiez M; on be..., Antimicrob Agents Chemother, 6/1/2014
• Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight Infants  
  Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, Herring A, Laughon MM, Carlton D, Hunt CE, J Pediatr, 5/1/2014
• Predictors of positive cerebrospinal fluid cultures in infants with bacteremia  
  Beam KS, Laughon MM, Hornik CP, Cohen-Wolkowiez M, Clark RH, Benjamin DK Jr, Smith PB, Pediatr Infect Dis J, 1/1/2014
• Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study  
  Onland W, Debray TP, Laughon MM, Miedema M, Cools F, Askie LM, Asselin JM, Calvert SA, Courtney SE, Dani C, Durand DJ, Marlow N, Peacock JL, Pillow JJ, Soll RF, Thome ..., BMC Pediatr, 12/17/2013
• Comparative effectiveness of surfactant preparations in premature infants  
  Trembath A, Hornik CP, Clark R, Smith PB, Daniels J, Laughon M; Best Pharmaceuticals for Children Act—Pediatric Trials Network, J Pediatr, 10/1/2013
• Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections  
  Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Mehta V, Walsh M, Kantak A, ..., Clin Infect Dis, 12/1/2012
• Group B Streptococcus and Escherichia coli Infections in the Intensive Care Nursery in the Era of Intrapartum Antibiotic Prophylaxis  
  Bauserman MS, Laughon MM, Hornik CP, Smith PB, Benjamin DK Jr, Clark RH, Engmann C, Cohen-Wolkowiez M, Pediatr Infect Dis J, 9/24/2012
• Predictors of bronchopulmonary dysplasia  
  Trembath A, Laughon MM, Clin Perinatol, 9/1/2012
• Feasibility study of early blood pressure management in extremely preterm infants  
  Batton BJ, Li L, Newman NS, Das A, Watterberg KL, Yoder BA, Faix RG, Laughon MM, Van Meurs KP, Carlo WA, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institut..., J Pediatr, 7/1/2012
• Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants  
  Smith PB, Ambalavanan N, Li L, Cotten CM, Laughon M, Walsh MC, Das A, Bell EF, Carlo WA, Stoll BJ, Shankaran S, Laptook AR, Higgins RD, Goldberg RN; Generic Database S..., Pediatrics, 6/1/2012
• Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first two postnatal weeks  
  Laughon M, Bose C, Allred EN, O'Shea TM, Ehrenkranz RA, Van Marter LJ, Leviton A; for the ELGAN Study Investigators, Pediatr Res, 6/3/2011
• Prevention of Chronic Lung Disease  
  Laughon M, Smith PB, Bose C, Archives of Diseases in Childhood: Neonatal-Perinatal Edition, 12/1/2009
• Comparison of Non-Invasive and Central Arterial Blood Pressure Measurements in Extremely Low Birth Weight Infants  
  Troy R, Doron M, Laughon M, Tolleson-Rinehart S, Price W, Journal of Perinatology, 11/1/2009
• Fetal growth restriction is followed by an increased risk of chronic lung disease among infants born before the 28th week of gestation  
  Bose C, Van Marter LJ, Laughon M, O'Shea M, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A, Pediatrics, 8/17/2009
• Chronic lung disease and the risk of developmental delay at two years of age in children without severe gross motor delays born before 28 weeks postmenstrual age  
  Laughon M, O'Shea TM, Allred EN, Bose C, Kuban K, Van Marter LJ, Ehrenkranz RA, Leviton A, Pediatrics, 7/20/2009
• Spontaneous Closure of the Patent Ductus Arteriosus in Very Low Birth Weight Infants Following Discharge from the Neonatal Unit  
  Herrman K, Bose C, Lewis K, Laughon M, Arch Dis Ch, 5/1/2008
• Join now to see all

Books/Book Chapters

• Handbook of Clinical Obstetrics: the Fetus & Mother 
  Chapter: Common Problems of the Newborn. 
  Page 526 - 539Moya F and Laughon MEditors: Reece EA, Hobbins JC, Gant Jr NF.Blackwell Publishing Ltd.2008

Abstracts/Posters

• Risk of Development of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants.
  Hupp S, Greenberg R, Cotten M, Clark R, Laughon M, Hornik C, Watt K, Smith PB, PAS, 1/1/2014
• Sedatives and Analgesics Given To Dying Infants in Neonatal Intensive Care Units.
  Zimmerman KO, Hornik CP, Watt KM, Clark RH, Laughon MM, Smith PB, PAS, 1/1/2014
• Analysis of the BPCA Priority List: Are Drug Priorities Reflective of Clinical Need in Hospitalized Infants?
  Gostelow M, Tripathi N, Benjamin Jr DB, Hornik CP, Cohen-Wolkowiez M, Clark R, Laughon MM, Smith PB, PAS, 1/1/2014
• Batton B, Li L, Newman N, Das A, Watterberg K, Yoder B, Faix R, Laughon M, Stoll B, Higgins R, PAS, 1/1/2014
• Management Practice and Mortality in Congenital Diaphragmatic Hernia (CDH).
  Malowitz JR, Hornik CP, Laughon MM, Cotten CM, Clark RH, Smith PB, PAS, 1/1/2013
• Hyperglycemia and Risk of Severe Retinopathy of Prematurity (ROP) in Extremely Low Birth Weight Infants.
  Lee JH, Hornik CP, Testoni D, Laughon MM, Cotten CM, Belcastro MR, Clark R, Smith PB, PAS, 1/1/2013
• Respiratory Support in Very Low Birth Weight (VLBW) Infants Receiving Dexamethasone.
  Virkud Y, Hornik CP, Benjamin DK, Laughon MM, Clark RH, Smith PB, PAS, 1/1/2013
• Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight Infants.
  Patel R, Clark J, Aliaga S, Vyas-Read S, Herring AH, Yoder BA, Clark R, Carlton DP, Smith PB, Laughon MM, PAS, 1/1/2013
• Review of Randomized Controlled Trials (RCTs) for the Prevention of Bronchopulmonary Dysplasia (BPD).
  Swan KN, Ahlfeld SK, Smith PB, Laughon MM, PAS, 1/1/2013
• Prospective Observational Study of Blood Pressure Management in Infants 23-26 Weeks Gestation.
  Batton BJ, Li L, Newman N, Thomas S, Das A, Watterberg KL, Yoder, BA, Faiz RG, Laughon MM, Stoll B, Higgins RD, Walsh MC, PAS, 1/1/2012
• Sildenafil exposure in the neonatal intensive care unit.
  Perez KM, Chantala K, Herring AH, Smith BP, Clark RH, Benjamin Jr DK, Cohen-Wolkowiez M, Laughon M, PAS, 1/1/2012
• Proxy-reported pulmonary outcomes scale for preterm infants with bronchopulmonary dysplasia.
  Massie SE, Tolleson-Rinehart S, Laughon MM, Powell LM, DeWalt DA, Magnus BE, Thissen D, Price WA, PAS, 1/1/2012
• Comparative effectiveness of three surfactant preparations in premature infants.
  Trembath A, Hornik C, Clark C, Clark R, Smith P, Beitzel M, Laughon M, PAS, 1/1/2012
• Decreasing incidence of neonatal invasive candidiasis.
  Aliaga S, Clark RH, Laughon M, Benjamin DK, Benjamin Jr DK, Smith PB, PAS, 1/1/2012
• Blood pressure values in the first 24 hours for infants 23-26 weeks gestation.
  Batton BJ, Li L, Newman N, Thomas S, Das A, Watterberg KL, Yoder, BA, Faiz RG, Laughon MM, Stoll B, Higgins RD, Walsh MC, PAS, 1/1/2012
• Neonatal practice variation influences outcomes for late preterm birth.
  Aliaga S, Boggess K, Ivester T, Price W, Laughon M, PAS, 1/1/2012
• Mortality of infants less than 30 weeks gestation by day of life.
  Smith PB, Sherwood A, Cotten CM, Hornik C, Laughon M, Clark R, PAS, 1/1/2012
• Comparison of invasive and non-invasive blood pressure measurements in infants.
  Dasnadi S, Aliaga S, Laughon M, Marshall DD, Tolleson-Rinehart S, Price W, PAS, 1/1/2012
• Association of in utero magnesium exposure with spontaneous intestinal perforations in very low birth weight infants.
  Downey CL, Asher SB, Cotten CM, Hornik CP, Laughon MM, Clark RH, Smith PB, PAS, 1/1/2012
• Early Blood Gas Predictors of Subsequent Respiratory Morbidities in Extremely Low Gestational Age Newborns.
  Condie J, Sriram S, Schreiber MD, Batton D, Shah B, Bose C, Laughon M, Van Marter L, Allred E, Leviton A, the ELGAN Study Investigators, PAS, 1/1/2011
• Assessment of Off-Label Prescribing Practices of Meropenem in Young Infants.
  S. Aliaga, P. B. Smith, R. Clark, M. Cohen-Wolkowiez, K. Wade, S. Massie, S. Tolleson-Rinehart, D. K. Benjamin, M. Laughon, PAS, 1/1/2011
• Regional Variation in Late Preterm Births in North Carolina.
  Aliaga S, Smith PB, Price W, Ivester T, Tolleson-Rinehart S, McCaffrey M, Laughon M, Southeastern Conference on Perinatal Research, Key Largo, FL, 2/1/2010
• Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants.
  Laughon M, Bose C, Allred EN, O'Shea TM, Ehrenkranz RA, Van Marter LJ, Leviton A, PAS, 1/1/2010
• The Epidmeiology of Group B Streptococcus and Escherichia coli infections in infants in the era of Intrapartum Antibiotic Prophylaxis.
  Bauserman M, Laughon M, Smith PB, Benjamin DK, Clark R, Engmann C, Cohen-Wolokowiez M, PAS, 1/1/2010
• Predictive Models of Bronchopulmonary Dysplasia by Postnatal Day in Preterm Infants.
  Laughon M, Langer J, Wilson D. Walsh M. (on behalf of the NICHD Neonatal Research Network), PAS, 1/1/2009
• Join now to see all

Other

• Dissemination of Information from Pediatric Studies Conducted under BPCA and PREA. 
  Smith PB, Laughon MM, National Academies of Science Institute of Medicine, Appendix B
  1/1/2013